Lier Chemical Co.,LTD. (SHE:002258)
China · Delayed Price · Currency is CNY 16.28
+0.20 (1.24%)
Feb 6, 2026, 2:15 PM CST
Lier Chemical Co.,LTD. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 9,008 | 7,298 | 7,831 | 10,120 | 6,476 |
Other Revenue | - | 13.11 | 19.31 | 16.29 | 18.16 |
| 9,008 | 7,311 | 7,851 | 10,136 | 6,494 | |
Revenue Growth (YoY) | 23.21% | -6.88% | -22.55% | 56.08% | 30.70% |
Cost of Revenue | 8,286 | 6,206 | 6,064 | 6,902 | 4,435 |
Gross Profit | 721.77 | 1,105 | 1,787 | 3,234 | 2,059 |
Selling, General & Admin | - | 492.55 | 559.54 | 480.4 | 374.02 |
Research & Development | - | 255.17 | 295.74 | 358.55 | 240.33 |
Other Operating Expenses | - | -0.37 | 25.03 | 23.63 | 26.31 |
Operating Expenses | - | 748.48 | 884.86 | 864.42 | 647.88 |
Operating Income | 721.77 | 356.08 | 902.16 | 2,369 | 1,411 |
Interest Expense | - | -85.07 | -49.18 | -65.97 | -88.71 |
Interest & Investment Income | - | 11.95 | 15.11 | 18.5 | 10.05 |
Currency Exchange Gain (Loss) | - | 44.7 | 22.33 | 121.36 | -16.46 |
Other Non Operating Income (Expenses) | -27.86 | -2.31 | -2.99 | -4.82 | -3.3 |
EBT Excluding Unusual Items | 693.91 | 325.36 | 887.43 | 2,438 | 1,313 |
Gain (Loss) on Sale of Investments | - | -0.91 | -11.92 | -13.43 | 21.35 |
Gain (Loss) on Sale of Assets | - | -4.65 | -2.28 | -58.55 | -41.84 |
Asset Writedown | - | -1.78 | -20.9 | -15.98 | -0.04 |
Other Unusual Items | - | 24.49 | 24.85 | 16.46 | 35.98 |
Pretax Income | 693.91 | 342.52 | 877.17 | 2,367 | 1,328 |
Income Tax Expense | 215.14 | 44.09 | 109.92 | 341.85 | 165.41 |
Earnings From Continuing Operations | 478.77 | 298.43 | 767.26 | 2,025 | 1,163 |
Minority Interest in Earnings | - | -83.09 | -163.37 | -212.49 | -90.26 |
Net Income | 478.77 | 215.34 | 603.89 | 1,813 | 1,072 |
Net Income to Common | 478.77 | 215.34 | 603.89 | 1,813 | 1,072 |
Net Income Growth | 122.33% | -64.34% | -66.68% | 69.02% | 75.17% |
Shares Outstanding (Basic) | 800 | 801 | 800 | 747 | 735 |
Shares Outstanding (Diluted) | 800 | 801 | 800 | 785 | 754 |
Shares Change (YoY) | -0.00% | 0.00% | 2.02% | 4.04% | -0.85% |
EPS (Basic) | 0.60 | 0.27 | 0.75 | 2.43 | 1.46 |
EPS (Diluted) | 0.60 | 0.27 | 0.75 | 2.31 | 1.42 |
EPS Growth | 122.34% | -64.34% | -67.34% | 62.45% | 76.67% |
Free Cash Flow | - | -870.37 | -1,034 | 387.66 | 515.48 |
Free Cash Flow Per Share | - | -1.09 | -1.29 | 0.49 | 0.68 |
Dividend Per Share | 0.200 | 0.200 | - | 0.500 | 0.357 |
Dividend Growth | - | - | - | 40.02% | 149.90% |
Gross Margin | 8.01% | 15.11% | 22.76% | 31.90% | 31.70% |
Operating Margin | 8.01% | 4.87% | 11.49% | 23.38% | 21.73% |
Profit Margin | 5.32% | 2.94% | 7.69% | 17.88% | 16.51% |
Free Cash Flow Margin | - | -11.91% | -13.16% | 3.82% | 7.94% |
EBITDA | 1,538 | 1,172 | 1,529 | 2,930 | 1,907 |
EBITDA Margin | 17.07% | 16.03% | 19.48% | 28.91% | 29.36% |
D&A For EBITDA | 815.94 | 815.94 | 626.83 | 561.18 | 495.49 |
EBIT | 721.77 | 356.08 | 902.16 | 2,369 | 1,411 |
EBIT Margin | 8.01% | 4.87% | 11.49% | 23.38% | 21.73% |
Effective Tax Rate | 31.00% | 12.87% | 12.53% | 14.44% | 12.46% |
Revenue as Reported | - | 7,311 | 7,851 | 10,136 | 6,494 |
Advertising Expenses | - | 21.12 | 14.91 | 7.49 | 7.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.